Sort   by:  
 Page size 
High-grade serous ovarian cancer (HGSC), the principal cause of death from gynecological malignancies in the world, has not significantly benefited from recent progress in cancer immunotherapy. While HGSC infiltration by lymphocytes correlates with superior survival, the nature of antigens that can ...
ORGANISM(S): Homo sapiens (Human) 
2020-02-18 | PXD014062 | Pride
Colorectal cancer is the second leading cause of cancer death worldwide, and the incidence of this disease is expected to increase as global socioeconomic changes occur. Immune checkpoint inhibition therapy is effective in treating a minority of colorectal cancer tumors; however, microsatellite stab...
ORGANISM(S): Homo sapiens (Human) 
2022-04-13 | PXD028309 | Pride
Immunotherapy in colorectal cancer (CRC) has largely focused on microsatellite instability (MSI) tumors, based on the assumption that high mutational burden drives immunogenicity. However, most CRCs are microsatellite-stable (MSS) and remain unresponsive to checkpoint blockade. Using proteogenomic p...
ORGANISM(S): Homo sapiens (Human) 
2026-05-26 | PXD071022 | Pride
CD8 T cells drive the anti-cancer immune response through the recognition of MHC I-associated peptides. In order to identify relevant targets for cancer immunotherapy in breast cancer, we characterized the immunopeptidome of 26 primary breast cancer samples from two different subtypes, hormone-recep...
ORGANISM(S): Homo sapiens (Human) 
2023-11-15 | PXD034818 | Pride
Sort   by:  
 Page size